Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-01-30

Clinical Trial Update: Effect of Liraglutide on Automated Closed-loop Glucose Control in Type 1 Diabetes [EARLY_Phase 1]

View source ↗

Summary

Phase 1 trial evaluating liraglutide in automated closed-loop glucose control for Type 1 Diabetes has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • liraglutide (liraglutide)

Snippet

Sponsor: Jennifer Sherr | Conditions: Type 1 Diabetes | EARLY_Phase 1 | Status: COMPLETED | Results posted: 2020-01-30